Back

Impact of established cardiovascular disease on treatment effect of stepwise versus standard dual antiplatelet in patients treated with drug-coated balloon: insights from the REC-CAGEFREE II trial

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Evolving strategies in coronary revascularisation: from devices to procedural optimisation Adjunctive Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chao Gao

First Affiliated Hospital of University of Science and Technology of China, Hefei (China)

6 More presentations in this session

Presentation thumbnail
Bioadaptor versus contemporary drug-eluting stents: Meta-analysis of randomized controlled trials
Doctor O. Kumet (Van, TR)
Abstract Slides Video
Presentation thumbnail
Does pre-dilatation balloon choice matter? standard versus specialized balloons prior to drug-coated balloon therapy in acute coronary syndrome patients
Doctor A. Darwish (Makkah, SA)
Abstract Slides Video
Presentation thumbnail
Drug-coated balloons versus drug-eluting stents following coronary atherectomy in severely calcified lesions: a systematic review and meta-analysis
Doctor A. Dos Santos Cleto (Indaiatuba, BR)
Abstract Slides Video
Presentation thumbnail
Adjunctive low-dose intracoronary thrombolysis during primary PCI in STEMI: an updated meta-analysis of randomised controlled trials
Miss S. Martinez-Topete (Tijuana, MX)
Abstract Slides Video
Presentation thumbnail
Length-to-diameter ratio predicts target lesion revascularization in patients undergoing percutaneous coronary intervention
Doctor V. Radl (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving strategies in coronary revascularisation: from devices to procedural optimisation

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 11
2 September 2024
thumbnail
Congress Presentation
Impact of stepwise dual antiplatelet therapy de-escalation in patients with high bleeding risk undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial
28 August 2026
thumbnail
Congress Presentation
Drug-coated balloon strategy and major bleeding in high-bleeding-risk acute coronary syndrome
29 August 2026
thumbnail
Congress Presentation
Discussant review - REC-CAGEFREE I
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources